Calcification in the CoreValve device "landing zone" shows a significant positive correlation to PAR after TAVI. Furthermore, the need for "second maneuvers" (i.e., post-dilation after initial device release) can be predicted by these calcification scores (AgS and DLZ-CS).

Calcium amount in the CoreValve DLZ in combination with clinical data could predict the need for post TAVI PM implantation.

A second CoreValve can be safely and effectively implanted in an in-series manner, without periprocedural complications. No problems arose on mid-term follow-up, ranging up to 20 months.

No abstract

It was the aim of the study to show that HES (Hydroxy-Ethyl-Starch) in intrauterine dystrophy identified by ultrasonography can increase fetal growth. Twenty pregnant women were treated in two groups (outpatients versus inpatients). Clinically, the result was satisfying.